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Abstract. 
 
We have isolated and characterized a 12-kb 
mouse genomic DNA fragment containing the entire 
calreticulin gene and 2.14 kb of the promoter region. 
The mouse calreticulin gene consists of nine exons and 
eight introns, and it spans 4.2 kb of genomic DNA. A 
1.8-kb fragment of the calreticulin promoter was sub-
cloned into a reporter gene plasmid containing 
chloramphenicol acetyltransferase. This construct was 
then used in transient and stable transfection of NIH/
3T3 cells. Treatment of transfected cells either with the 
 
Ca
 
2
 
1
 
 ionophore A23187, or with the ER Ca
 
2
 
1
 
-ATPase 
inhibitor thapsigargin, resulted in a five- to sevenfold 
increase of the expression of chloramphenicol acetyl-
transferase protein. Transactivation of the calreticulin 
promoter was also increased by fourfold in NIH/3T3 
cells treated with bradykinin, a hormone that induces 
Ca
 
2
 
1
 
 release from the intracellular Ca
 
2
 
1
 
 stores. Analy-
sis of the promoter deletion constructs revealed that 
A23187- and thapsigargin-responsive regions are con-
fined to two regions (
 
2
 
115 to 
 
2
 
260 and 
 
2
 
685 to 
 
2
 
1,763) in the calreticulin promoter that contain the 
CCAAT nucleotide sequences. Northern blot analysis 
of cells treated with A23187, or with thapsigargin, re-
vealed a fivefold increase in calreticulin mRNA levels. 
Thapsigargin also induced a fourfold increase in cal-
reticulun protein levels. Importantly, we show by nu-
clear run-on transcription analysis that calreticulin gene 
transcription is increased in NIH/3T3 cells treated with 
A23187 and thapsigargin in vivo. This increase in gene 
expression required over 4 h of continuous incubation 
with the drugs and was also sensitive to treatment with 
cycloheximide, suggesting that it is dependent on pro-
tein synthesis. Changes in the concentration of extracel-
lular and cytoplasmic Ca
 
2
 
1
 
 did not affect the increased 
expression of the calreticulin gene. These studies sug-
gest that stress response to the depletion of intracellu-
lar Ca
 
2
 
1
 
 stores induces expression of the calreticulin 
gene in vitro and in vivo.
 
A
 
lterations
 
 in intracellular Ca
 
2
 
1
 
 concentration regu-
late a variety of diverse cellular functions including
secretion, contraction–relaxation, cell motility, cy-
toplasmic and mitochondrial metabolism, and protein syn-
thesis and folding (Pozzan et al., 1994). Ca
 
2
 
1
 
 signals also
trigger gene expression, promote cell cycle progression,
and activate apoptosis (Schönthal et al., 1991; Little et al.,
1994; Ghosh and Greenberg, 1995). The ER is considered
one of the most important and metabolically relevant
sources of cellular Ca
 
2
 
1
 
 (Pozzan et al., 1994). Ca
 
2
 
1
 
 is re-
leased from the ER by InsP
 
3
 
 receptor/ryanodine receptor
Ca
 
2
 
1
 
 release channels and it is taken up by the Ca
 
2
 
1
 
-ATP-
ase (Sorrentino and Volpe, 1993; Pozzan et al., 1994; Coro-
nado et al., 1994). The ER contains a characteristic set of
proteins, resident in the lumen, which terminates with the
KDEL ER retrieval signal (Pelham, 1989) and may be in-
volved in Ca
 
2
 
1
 
 storage. The most extensively studied of
these proteins are Grp78 (BiP), Grp94, ERp72, protein
disulfide isomerase (PDI), and calreticulin (Pozzan et al.,
1994). These proteins appear also to be involved in many
other aspects of ER function, including protein synthesis
and folding (Gething and Sambrook, 1992). Recently,
Lee’s group has shown that the expression of Grp78 and
Grp94 is induced by various physiological stresses includ-
ing glucose starvation, heat shock, and changes in intracel-
lular Ca
 
2
 
1
 
 concentration (Little et al., 1994).
Calreticulin is an unusual luminal ER protein. Several
unique functions have been postulated for the protein, in-
cluding modulation of gene expression (Burns et al., 1994;
Dedhar et al., 1994; Michalak et al., 1996), a role in cell ad-
hesion (Coppolino et al., 1995; Opas et al., 1996), and
maintenance of intracellular Ca
 
2
 
1
 
 homeostasis including
control of store-operated Ca
 
2
 
1
 
 influx (Liu et al., 1994; Ca-
macho and Lechleiter, 1995; Bastianutto et al., 1995; Mery
et al., 1996). An important recent finding is that it is the
ER form of calreticulin that modulates gene expression
and cell adhesiveness in mouse L fibroblasts (Michalak et
al., 1996; Opas et al., 1996). Calreticulin has chaperone ac-
tivity (Nigam et al., 1994; Nauseef et al., 1995; Wada et al.,
1995; Peterson et al., 1995; Sapiro et al., 1996; Otteken and
Moss, 1996; Van Leeuwen and Kearse, 1996; Helenius et
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al., 1997) and it is similar to calnexin, an integral ER mem-
brane protein chaperone (Bergeron et al., 1994; Michalak,
1996; Krause and Michalak, 1997). Calreticulin and cal-
nexin are unusual as chaperones because they function
like lectins and bind specifically to partially trimmed,
monoglucosylated, N-linked oligosaccharides (Ware et al.,
1995; Hammond and Helenius, 1995; Peterson et al., 1995;
Sapiro et al., 1996; Helenius et al., 1997). Calreticulin also
has an antithrombotic activity (Kubawara et al., 1995) and
it is detected on the cell surface (Gray et al., 1995; White et
al., 1995). The protein plays a role in long term “memory”
in 
 
Aplysia
 
 (Kennedy et al., 1992), in cytotoxic T cell func-
tion/activation (Burns et al., 1992; Dupuis et al., 1993), in
neutrophils (Stendhal et al., 1994), in viral RNA replica-
tion (Singh et al., 1994), in sperm cell function (Nakamura
et al., 1993), and in autoimmunity (Sontheimer et al.,
1993). To rationalize these diverse functions of calreticu-
lin, it is important to identify and understand the mecha-
nisms that regulate its expression. It is apparent that dif-
ferential expression of calreticulin will have profound
effects on these seemingly diverse cellular functions. The
human calreticulin gene has been isolated, and the nucle-
otide sequence analysis of its promoter region has re-
vealed several sites that might play a role in regulation of
transcription (McCauliffe et al., 1992).
In the present study we describe isolation of the mouse
calreticulin gene, including 2.14 kb of its promoter region.
Using reporter genes we show that this promoter is sensi-
tive to the ER Ca
 
2
 
1
 
 store depletion. We demonstrate that,
in mouse fibroblasts, both the Ca
 
2
 
1
 
 ionophore A23187 and
the ER Ca
 
2
 
1
 
-ATPase inhibitor thapsigargin stimulate ex-
pression of the calreticulin gene. We also show, by the nu-
clear run-on transcription assay, that calreticulin gene is
activated by A23187 and thapsigargin in vivo. Over 4 h of
continuous treatment with these drugs was required to in-
duce calreticulin expression, and this stimulation was sen-
sitive to cycloheximide, suggesting that the Ca
 
2
 
1
 
 store de-
pletion–dependent induction of calreticulin expression
requires new protein synthesis. Importantly, transactiva-
tion of calreticulin promoter was also induced by bradyki-
nin treatment of NIH 3T3 cells. Our results suggest that
stress response to the depletion of intracellular Ca
 
2
 
1
 
 stores
plays a very important role in the regulation of calreticulin
gene expression in vitro and in vivo.
 
Materials and Methods
 
Isolation and Sequencing of Genomic Clones
 
A mouse liver genomic library (a gift from Dr. J. Stone, University of Al-
berta, Canada) was constructed by partial digestion of genomic DNA
(adult 129/J male) with the restriction enzyme Sau3A, followed by cloning
into the BamHI site of lambda DASH (Stratagene, La Jolla, CA). Screen-
ing of the library was carried out as described by Dower et al. (1992) using
GeneScreen Plus hybridization membrane (NEN, DuPont, Mississaga,
Canada). DNA probes were labeled with [
 
32
 
P]CTP (NEN, DuPont) by
random priming. The first screening of the library, with a 711-bp cDNA
fragment corresponding to the 5
 
9
 
-coding region of mouse calreticulin
cDNA (nucleotides 163–874) (Smith and Koch, 1989), resulted in the iso-
lation of a pseudogene. A second DNA probe was produced by PCR-
driven amplification of mouse genomic DNA using the following primers:
T1 (5
 
9
 
-GCGAA TTC AAA GAG CAG TTC TTG GAC GG-3
 
9
 
) corre-
sponding to nucleotides 137–158 of mouse calreticulin cDNA (
 
underlined
 
)
with a 5
 
9
 
 EcoRI restriction site, and T2 (5
 
9
 
-CTGGAT CCA CTC GGA
AAC AGC TTC ACG-3
 
9
 
) corresponding to nucleotides 396–416 (
 
under-
lined
 
) and a 5
 
9
 
 BamHI restriction site. The PCR product was inserted be-
tween the EcoRI–BamHI restriction sites of pBluescript, and its nucle-
otide sequence was confirmed (see below). Screening of the mouse
genomic DNA library with this probe resulted in the isolation of one
clone, designated p1.3. This clone was further characterized by Southern
blotting (Ausubel et al., 1989).
Various fragments of p1.3 were subcloned into pBluescript and their
nucleotide sequences were determined by the double-stranded dideoxy-
nucleotide method. Sequencing was performed in the DNA Sequencing
Laboratory of the Department of Biochemistry, using DNA sequencer
(model 373A; Applied Biosystems, Foster City, CA). T3, T7, or custom-
made primers were used for the sequencing reactions. Synthetic oligode-
oxynucleotides were made in the DNA Sequencing Laboratory of the De-
partment of Biochemistry, using a DNA/RNA synthesizer (model 392;
Applied Biosystems).
 
Plasmid Construction
 
Plasmid pCM7 was constructed by subcloning a 7-kb HindIII restriction
fragment from p1.3 into the HindIII restriction site of pBluescript. This
fragment contained 1.8 kb of the 5
 
9
 
-flanking region and the entire coding
region of the calreticulin gene. The 1.8-kb promoter fragment was further
subcloned into the promoterless chloramphenicol acetyltransferase
(CAT)
 
1
 
 reporter expression vector pCATbasic and pXP-1 (luciferase ex-
pression vector [De Wet et al., 1987] producing plasmids pCC1 and pLC1,
respectively). To generate pCC1, a HindIII/StuI fragment of pCM7 (nu-
cleotides 
 
2
 
1,723 to 
 
1
 
40 of the calreticulin gene; Fig. 1) was cloned into
the blunt-ended XbaI/HindIII sites of pCATbasic. To generate pLC1, an
SmaI/StuI fragment was subcloned into the SmaI restriction site of pXP-1.
Different restriction fragments of the calreticulin promoter were sub-
cloned into the promoterless reporter plasmids pCATbasic (CAT expres-
sion vector) to generate promoter deletion constructs: pCC0 (2,142-bp
SmaI/StuI restriction fragment of the promoter DNA), pCC1 (1,763-bp
HindIII/StuI restriction fragment), pCC2 (685-bp KpnI/StuI restriction
fragment), pCC3 (415-bp AflII/StuI restriction fragment), pCC4 (260-bp
BamHI/StuI restriction fragment), and pCC5 (115-bp PvuI/StuI restric-
tion fragment).
 
Cell Culture and Drug Treatment
 
All cell lines were maintained in DME supplemented with 10% calf serum
at 37
 
8
 
C with 5% CO
 
2
 
 in a humidified incubator. Cells were transferred to
10- or 2-cm tissue culture plates 1 d before drug treatment. Stock solutions
of A23187, thapsigargin, BAPTA/AM (Molecular Probes, Inc., Eugene,
OR), and EGTA/AM (Molecular Probes, Inc.) were prepared in 99.5%
dimethyl sulfoxide and were added to the culture medium as specified in
the text. Control cells were incubated with appropriate volume of 99.5%
dimethyl sulfoxide. Cycloheximide and bradykinin were dissolved in water.
 
Transient and Stable Transfection
 
Plasmid DNA was purified by column chromatography (QIAGEN Inc.,
Chatsworth, CA). NIH/3T3 cells were grown in 10-cm dishes and trans-
fected using the calcium phosphate method and a BES (
 
N
 
,
 
N
 
-bis (2-hydrox-
yethyl)-2-aminoethanesulfonic acid) buffer (Ausubel et al., 1989). For
transient transfection, 10 
 
m
 
g of reporter plasmid and 10 
 
m
 
g of pSV
 
b
 
-
gal (internal control) were used per dish. Cells were incubated with the
precipitated DNA for 16–20 h. After an additional 8-h incubation, cells
were treated with the appropriate drugs for the indicated times, and cell
extracts were prepared and assayed for the reporter genes.
For stable transfection, NIH/3T3 cells were cotransfected with reporter
plasmid (8 
 
m
 
g), pSV
 
b
 
gal (8 
 
m
 
g), and pNEO1 (0.5 
 
m
 
g). After a 24-h incuba-
tion, cells were selected for resistance to Geneticin (G418) (600 
 
m
 
g/ml).
After 14 d of growth in the presence of G418, 
 
z
 
200 clones were obtained.
These G418-resistant cells were tested for expression of the reporter gene
and 
 
b
 
-galactosidase.
 
Cell Extraction and Reporter Assays
 
Cell extracts were prepared by washing cells with PBS followed by incuba-
tion for 15 min at room temperature with 100 
 
m
 
l per 2-cm dish of a lysis
 
1. 
 
Abbreviations used in this paper
 
: CAT, chloramphenicol acetyltrans-
ferase; G3PDH, glyceraldehyde-3 phosphate dehydrogenase; PDI, pro-
tein disulfide isomerase. 
Waser et al. 
 
Calreticulin Gene
 
549
 
buffer containing 100 mM Tris, pH 7.8, 0.5% NP-40, and freshly added 1
mM DTT. Cell extracts were collected and stored at 
 
2
 
80
 
8
 
C until further use.
The level of CAT protein in cell extracts was determined using a CAT
ELISA kit with specific anti-CAT antibodies (Boehringer Mannheim Bio-
chemicals, Indianapolis, IN). Luciferase activity was assessed using 10 
 
m
 
l
of cell lysate and 100 
 
m
 
l of luciferase assay reagent (containing 20 mM Tri-
cine, 1.07 mM MgCO
 
3
 
, 2.67 mM MgSO
 
4
 
, 0.1 mM EDTA, 33.3 mM DTT,
270 
 
m
 
M coenzyme A, 530 
 
m
 
M ATP, and 470 
 
m
 
M luciferin). CAT levels
and luciferase activities in cell extracts were always normalized against
 
b
 
-galactosidase activity. 
 
b
 
-Galactosidase activity was measured by incu-
bating 20 
 
m
 
l of cell lysate in a covered microtiter plate, at 37
 
8
 
C, with 100 
 
m
 
l
of ONPG (
 
o
 
-nitrophenyl-
 
b
 
-
 
d
 
-galactopyranoside) solution (0.8 mg/ml) and
the OD was measured at 420 nm. Data are reported as means 
 
6
 
 SD of
four separate experiments performed in triplicate.
 
Nuclear Run-on Transcription Assay
 
Nuclei were prepared from the cells treated for 4 h with 10 
 
m
 
M A23187 or
100 nM thapsigargin. The elongating RNA transcripts were labeled in
vitro with [
 
32
 
P]UTP, isolated, and hybridized to membranes (GeneScreen
Plus) containing slot-blotted single-stranded bacteriophage M13 DNA
probes specific for mouse calreticulin gene. The probes were designed to
detect either sense or antisense transcription in the gene region of inter-
est. The following DNA probes were used in the assay, all cloned into
M13mp18 and M13mp19 (Rice et al., 1995): the mouse calreticulin 5
 
9
 
probe was a 700-bp (from 
 
1
 
44 to 
 
1
 
744) fragment of the murine calreticu-
lin cDNA; the mouse calreticulin 3
 
9
 
 probe was a 630-bp (from 
 
1
 
750 to
 
1
 
1,380) fragment of the murine calreticulin cDNA; the mouse Exon 1
c-
 
myc
 
 probe was a 436-bp HindIII–BglII fragment extending from 
 
1
 
140
to 
 
1
 
576 of the murine c-
 
myc
 
 gene; the mouse Intron 1 c-
 
myc
 
 probe was an
816-bp BglII–SstI fragment from 
 
1
 
700 to 
 
1
 
1,516 of the murine c-
 
myc
 
gene; the glyceraldehyde-3 phosphate dehydrogenase (G3PDH) probe
was a 979-bp fragment from 
 
1
 
44 to 
 
1
 
1,023 of a human G3PDH cDNA;
the 
 
g
 
-actin 5
 
9
 
 probe was a 583-bp BamHI-BglI fragment from 
 
1
 
483 to
 
1
 
1,083 (Exon 4–6) of a human 
 
g
 
-actin cDNA; the histone H2b probe was
a 300-bp BstEII fragment from 
 
1
 
110 to 
 
1
 
412 of the chicken histone H2b
gene. Radioactivity hybridizing to each probe was quantitated with a Fujix
BAS1000 Phosphorimager (Fuji Photo Film Co., Ltd., Tokyo, Japan) us-
ing MacBAS imaging software.
 
Northern and Western Blot Analysis
 
Northern blot analysis was carried out as described by Burns et al. (1992).
The 711-bp, 5
 
9
 
 portion of mouse calreticulin cDNA was used as a probe.
The blots were normalized with a human G3PDH cDNA probe (Clontech
Laboratories, San Diego, CA) (Burns et al., 1992). The relative abun-
dance of each mRNA was determined using a Fujix BAS1000 Phosphor-
imager. Cellular extracts were prepared for immunoblotting as described
by Mery et al. (1996). Cells were directly lysed into Laemmli sample
buffer followed by sonication (Mery et al., 1996). Proteins were separated
by SDS-PAGE on 10% polyacrylamide gels as described by Laemmli
(1970), and then transferred to nitrocellulose membranes (Towbin et al.,
1979). Immunoblotting was carried out with goat anti-calreticulin as de-
scribed by Milner et al. (1991).
 
Measurements of Intracellular Ca
 
2
 
1
 
 Concentration in 
Cycloheximide- and BAPTA-treated Cells
 
For measurement of the intracellular Ca
 
2
 
1
 
 concentration in cyclohexi-
mide-treated (2 h with 100 
 
m
 
M cycloheximide) or control cells, NIH/3T3
cells (2 
 
3
 
 10
 
7
 
 per ml) were loaded for 30 min with 2 
 
m
 
M fura-2/AM under
the conditions preventing sequestration of the dye into subcellular or-
ganelles (Demaurex et al., 1992; Mery et al., 1996). The cells were washed
twice and fluorescence measurements were performed while cells were
continually stirred and maintained at 37
 
8
 
C. Fura-2 fluorescence was moni-
tored at 
 
l
 
ex
 
 
 
5
 
 340 nm. To determine effects of BAPTA on the intracellu-
lar Ca
 
2
 
1
 
 concentration, NIH/3T3 cells were loaded with both 2 
 
m
 
M fura-2/
AM and 20 
 
m
 
M BAPTA/AM as described by Muallem et al. (1990). The
basal cytosolic Ca
 
21 concentrations are reported as means 6 SD of four
separate experiments performed in triplicate.
Results
Isolation and Characterization of the Mouse 
Calreticulin Gene
To isolate a calreticulin genomic clone, we first screened a
mouse liver genomic DNA library with a cDNA probe
corresponding to the 59-coding region of mouse calreticu-
lin cDNA. Four clones were isolated and nucleotide se-
quence analysis revealed that each of them represented an
intronless fragment of the calreticulin gene. The nucle-
otide sequences of these clones were identical to the nu-
cleotide sequence of the 39 region of calreticulin cDNA,
and they were missing introns 6, 7, and 8 that were subse-
quently found in the calreticulin gene (see below). The 59
regions of these clones did not align with any nucleotide
sequences in the EMBL gene database. We concluded that
these clones correspond to a calreticulin pseudogene. Iso-
lation of the calreticulin genomic clone was achieved by
further screening of the same library, with a genomic
probe that did not hybridize to the pseudogene. Screening
of .300,000 plaques resulted in the isolation of a single
clone, designated p1.3. This clone has an insert of 12 kb
that contains the entire calreticulin gene and 2.14 kb of the
59-untranslated region.
The mouse calreticulin gene has nine exons and eight in-
trons. The different lengths of these coding and noncoding
regions of the gene are summarized in Table I. The exon–
intron boundaries are highly homologous to the reported
mammalian exon–intron consensus sequences (Table I).
However, there is no typical poly(A) signal in the 39-untrans-
lated region. Nucleotide sequencing of the exons revealed
that they are virtually identical to the mouse cDNA. Specif-
ically, only two nucleotides differ compared with the nu-
cleotide sequence of mouse calreticulin cDNA reported
by Mazzarella et al. (1992), and only four differ compared
with the sequence reported by Smith and Koch (1989). Im-
portantly, these variations in the nucleotide sequence do
not affect the amino acid sequence of the protein.
Fig. 1 shows the nucleotide sequence of the 1,723-bp
promoter region of the mouse calreticulin gene. The se-
quence was compared with a database of transcriptional
control elements using MacVector v4.5 software. The fol-
lowing putative regulatory elements were found: a TATA
box (nucleotides 230 to 225), several AP-2 sites (nucle-
otides 274, 2258, 2300, 2305, 2518, 2553, 21,091, 21,098,
21,251, and 21,477), GC-rich areas including SpI sites
(nucleotides 276, 2303, and 2312), AP-1 sites (nucle-
Table I. Exons amd Introns of the Mouse Calreticulin Gene
Splice junction consensus sequence
No. Exon Intron AGGTG/AAGT NCAGG*
bp bp
I 158 358 AGGTAAGG TCAGA
II 102 184 AGGTACAA ACAGG
III 204 897 TGGTGAGG ATAGG
IV 95 87 AGGTGTGC TCAGG
V 210 82 AGGTTAGT CTAGG
VI 114 169 AGGTAGGC ACAGG
VII 144 1030 AGGTGAGA CCAGG
VIII 93 100 AGGTGTGT ACAGG
IX 733 through poly (A) signal sequence
*Mammalian consensus nucleotide sequence (Senapathy et al., 1990).The Journal of Cell Biology, Volume 138, 1997 550
otides 21,034 and 21,378), an SIF PDGF binding site (nu-
cleotide 2404), an H4TF-1 site (2183), and four CCAAT
sequences (nucleotides 2194, 2207, 21,123, and 21,532),
three of which are oriented in the forward direction. AP-2
and H4TF-1 recognition sequences are typically found in
genes that are active during cellular proliferation, and this
is consistent with the finding that calreticulin expression is
increased in stimulated T cells (Burns et al., 1992).
Comparison of the Mouse and Human
Calreticulin Genes
The genomic organization and nucleotide sequence of the
mouse calreticulin gene are very similar to those reported
for the human gene (McCauliffe et al., 1992). The nucle-
otide sequences of the mouse and the human gene show
.70% identity (calculated by BESTFIT; Genetics Com-
puter Group software, Madison, WI), with the exception
of introns 3 and 6. There are also remarkable similarities
in the lengths of the exons and introns of both genes. Fig. 2
shows a DNA dot matrix analysis of the mouse calreticulin
gene compared with the human gene. The coding regions,
especially, show a high degree of identity, and the only sig-
nificant differences between the two genes are centered
around introns 3 and 6. In the mouse gene these introns
are approximately twice the size of the corresponding in-
trons in the human gene (897 bp vs 421 bp for intron 3, and
169 bp vs 88 bp for intron 6).
Several putative regulatory elements are found in the
promoter region of both genes. However, there are differ-
ences between the two promoters in the position and num-
ber of these sites. For example, in the 526-bp promoter re-
gion, there are only two CCAAT sites found in the mouse
gene, but four in the human gene (Fig. 1). Three Sp-1 sites
are located in the first 500 bp of the mouse promoter com-
pared with only two in the human gene. In this same re-
gion, there are five AP-2 sites in the mouse promoter and
only one in the human gene (McCauliffe et al., 1992). No
SIF PDGF binding site is found in the human gene, but
both promoters contain several poly G-rich sequences.
The Calreticulin Promoter Is Activated by Changes
in Intracellular Ca21 Concentration
The availability of the promoter from the mouse calreticu-
lin gene has allowed us to study how it might regulate tran-
scription. To do this, two different reporter gene systems
were used. The 1.8-kb calreticulin promoter region was
cloned into CAT and luciferase expression plasmids, as
described in Materials and Methods, to generate plasmids
pCC1 and pLC1, respectively. These plasmids were then
used for transient and stable transfection of NIH/3T3 cells.
pSVb-galactosidase was used as an internal control. Basal
levels of CAT protein and luciferase activity were ob-
served in both stably and transiently transfected NIH/3T3
cells, whereas cells transfected with promoterless control
plasmids showed no detectable CAT protein or luciferase
activity (data not shown). Once cells had been transfected,
we investigated whether alteration of intracellular Ca21
levels, using either A23187 or thapsigargin, affected the
activity of the calreticulin promoter. A23187, a Ca21 iono-
phore, equilibrates any Ca21 gradient across membranes.
Thapsigargin, however, leads to the depletion of the ER
Ca21 stores by inhibiting the ER Ca21-ATPase (Thastrup
et al., 1990; Ghosh et al., 1991).
Figure 1. The nucleotide sequence of the promoter region of the
mouse calreticulin gene. The nucleotides are numbered with the
putative transcriptional initiation site of the mouse calreticulin
gene at 11 (Smith and Koch, 1989). (Horizontal lines) Putative
binding sites for the DNA binding proteins: AP-2, Sp1, AP-1 and
H4TF-1, and SIF. CCAAT sites (boxed). TATA box (under-
lined). ATG initiation codon (bold). These sequence data are
available from GenBank/EMBL/DDBJ under accession number
U38249.
Figure 2. DNA dot matrix comparison of the mouse and the hu-
man calreticulin gene. DNA dot matrix analysis was carried out
using MacVector v4.5 software with the following settings: win-
dows size 30, minimum score 65%, and hash value 6. The nucle-
otide sequence 2526 to 15,023 of the mouse gene was compared
with nucleotide sequence 2529 to 14,418 of the human gene.
(Bottom) The intron–exon configuration of the mouse calreticu-
lin gene. (Empty boxes) Exons, numbered from 1 to 9. (Filled
box) The 526-bp promoter region of the mouse gene.Waser et al. Calreticulin Gene 551
Fig. 3 shows that NIH/3T3 cells stably transfected with
pCC1 and pSVb-galactosidase produced five- to sevenfold
more CAT protein after treatment for 16 h with 7 mM
A23187 or 100 nM thapsigargin. NIH/3T3 cells were also
stably transfected with pLC1 and pSVb-galactosidase.
When these cells were treated with 7 mM A23187 or 100
nM thapsigargin, a threefold increase in luciferase activity
was observed (Fig. 3 A). Similar results were obtained
with mouse fibroblasts that were transiently transfected
with pCC1 or pLC1. The reason for this difference be-
tween the CAT and luciferase reporter systems is not
clear, but it may be related to an inhibitory effect of Ca21
on luciferase activity (unpublished observations).
To identify regions in the calreticulin promoter that may
be responsible for the A23187- and thapsigargin-depen-
dent activation of the calreticulin gene, we have generated
constructs containing several deletions in the calreticulin
promoter. Fig. 3 B shows that the first 115-bp DNA frag-
ment of the calreticulin promoter was not activated by
A23187 or thapsigargin. The region encompassing 2115 to
2260 was responsible for two- to threefold A23187- and
thapsigargin-dependent induction of the calreticulin pro-
moter (Fig. 3 B). Additional activation of the promoter by
A23187 and thapsigargin was observed within the second
region of calreticulin promoter localized between 2685
and 21,763 (Fig. 3 B). These two regions of calreticulin
promoter contain the CCAAT nucleotide motif that, at
least in part, may be responsible for the Ca21 store deple-
tion–dependent activation of the calreticulin gene as
shown for transactivation of the Grp78 (BiP) promoter
(Wooden et al., 1991; Roy and Lee, 1995; Roy et al., 1996).
The Expression of Calreticulin mRNA and Protein Is 
Induced by A23187 and Thapsigargin in NIH/3T3 Cells
Treatment of nontransfected cells with A23187 and thapsi-
gargin also led to altered expression of the endogenous
calreticulin gene. Specifically, we used Northern blot anal-
ysis to measure the relative mRNA levels in NIH/3T3 cells
treated with these drugs. Fig. 4 A shows that an approxi-
mately four- to fivefold increase in the abundance of cal-
reticulin mRNA was observed in cells incubated with
these drugs. There was an approximately fourfold increase
in calreticulin protein in NIH/3T3 cells incubated with
thapsigargin (Fig. 4 B). This suggests that changes in the
level of calreticulin mRNA resulted in changes in calretic-
ulin expression.
The Endogenous Calreticulin Gene Is Activated by 
A23187 and Thapsigargin in NIH/3T3 Cells
To measure transcription rates of the endogenous calretic-
ulin gene and to determine if the accumulation of calretic-
ulin mRNA was the result of increased transcription due
to A23187 and thapsigargin, nuclear run-on transcription
assays were carried out. NIH/3T3 cells were treated for 4 h
with either A23187 or thapsigargin. Nuclei were prepared
from the drug-treated cells and RNA transcripts initiated
in vivo were elongated in vitro in the presence of
[32P]UTP. The radiolabeled run-on transcripts were hy-
bridized to single-stranded DNAs complementary to ei-
ther specific calreticulin or control mRNAs (sense probes)
or to antisense RNAs from the same regions (antisense
probes). The probes used detected two regions of the
mouse calreticulin gene (59 and 39 regions). Single-stranded
probes for the two regions of the g-actin gene, G3PDH
gene, histone H2b gene, and c-myc gene (intron 1 and
exon 1 regions) were included as controls for levels of
transcription. Fig. 5 shows that both A23187 and thapsi-
gargin induced transcription of calreticulin gene and that
the transcription pattern was consistent with A23187- and
thapsigargin-dependent accumulation of calreticulin mRNA
(Fig. 5). The relative abundance of the calreticulin signal
was determined using Phosphorimager analysis of the
Figure 3. Activation of the calreticulin promoter by A23187 and
thapsigargin treatment. (A) NIH/3T3 were stably transfected
with either pCC1 or pLC1 and pSVLb-galactosidase as described
in Materials and Methods. Cells were incubated for 16 h with 7
mM A23187, 100 nM thapsigargin, or an appropriate volume of
DMSO (control cells), as described in Materials and Methods.
(B) Different fragments of the calreticulin promoter were sub-
cloned into the promoterless reporter plasmids pCATbasic (CAT
expression vector) as described in Materials and Methods. Vec-
tors pCC0, pCC1, pCC2, pCC3, pCC4, and pCC5 contained the
2,142-, 1,763-, 685-, 415-, 260-, and 115-bp DNA fragments of the
calreticulin promoter, respectively. NIH/3T3 were transiently
transfected with different pCC vectors and pSVLb-galactosidase
as described in Materials and Methods. Cells were incubated for
16 h with 7 mM A23187 (open bars) or 300 nM thapsigargin (filled
bars) and lysed, and reporter enzyme assays were carried out. n/d,
not detectable. Data shown are means 6 SD of four separate ex-
periments performed in triplicate.The Journal of Cell Biology, Volume 138, 1997 552
blots shown in Fig. 5. Comparison of the levels of calretic-
ulin gene transcription between control and drug-treated
cells relative to that observed for G3PDH revealed an
approximately twofold increase in the calreticulin signal
(Fig. 5). When levels of calreticulin gene transcription
were compared between control and drug-treated cells rel-
ative to g-actin, H2b, and c-myc gene transcription, an ap-
proximately sixfold increase in calreticulin signal was ob-
served. Control genes (G3PDH, H2b, and c-myc) were
also induced in the presence of A23187 and thapsigargin
but to a lesser extent than that observed for calreticulin
gene (Fig. 5). These results indicate that treatment of the
cells with the Ca21 ionophore A23187, or with thapsigar-
gin, induces the expression of calreticulin at the transcrip-
tional level in vivo.
The Kinetics of Activation of the Calreticulin Promoter
A23187 and thapsigargin modulate intracellular Ca21 con-
centration within seconds. To determine the kinetics of the
Ca21-dependent activation of calreticulin promoter, time-
dependent expression of CAT was measured in NCB1
cells (NIH/3T3 cells stably transfected with pCC1 and
pSVb-galactosidase). Two experimental protocols were
used for this analysis. First, the cells were incubated for 2,
4, 8, 12, and 16 h with A23187 or thapsigargin followed by
measurement of CAT expression (Fig. 6, open bars). In
the second protocol, the cells were incubated for 2, 4, 8,
and 12 h with the drugs followed by incubation in a drug-
free medium to a total of 16 h of incubation for each data
point (Fig. 6, hatched bars). Fig. 6 shows that for both pro-
tocols the overall kinetics and magnitude of induction of
CAT expression by A23187 and thapsigargin were similar.
Maximal induction of CAT expression in the NCB1 cells
required 16 h of continuous incubation with both drugs
(Fig. 6), or exposure to the drugs for 4–8 h followed by in-
cubation in a drug-free medium to a total of 16 h (Fig. 6).
These results indicate that the Ca21 store depletion–depen-
dent activation of the calreticulin promoter is very slow
and that it may require de novo protein synthesis.
In previous experiments with untransfected NIH/3T3
cells (Fig. 4), we found that treatment with A23187 or
thapsigargin induced expression of calreticulin mRNA. To
assess whether or not new protein synthesis is required to
mediate this change, NIH/3T3 cells were pretreated with
100 mM cycloheximide before the addition of either 7 mM
A23187 or 100 nM thapsigargin. Total RNA was then iso-
Figure 4. A23187- and thapsigargin-dependent increase in cal-
reticulin mRNA levels (A) and protein levels (B). (A) Nontrans-
fected NIH/3T3 cells were incubated for 16 h with 7 mM A23187,
100 nM thapsigargin, or DMSO. Total RNA was then isolated
and electrophoretically separated on a formaldehyde-agarose gel,
blotted onto Hybond N nylon membrane, and hybridized with
cDNA probes encoding mouse calreticulin and G3PDH, as de-
scribed in Materials and Methods. (Top) Autoradiogram of a
Northern blot probed with calreticulin and G3PDH cDNA.
(Lane 1) Control cells; (lane 2) A23187-treated cells; (lane 3)
thapsigargin-treated cells. (Bottom) The abundance of calreticu-
lin mRNA (calreticulin mRNA/G3PDH mRNA ratio) was deter-
mined using Phosphorimager analysis of Northern blots. (B)
NIH/3T3 cells were incubated for 16 h with 100 nM thapsigargin
and cellular extracts were prepared as described by Mery et al.
(1996). The proteins were separated by SDS-PAGE, transferred
electrophoretically to nitrocellulose membranes, and incubated
with goat anti-calreticulin antibody as described by Milner et al.
(1991). For each condition, three different amounts of cells were
analyzed (lanes 1 and 4, 30,000 cells per well; lanes 2 and 5,
100,000 cells per well; lanes 3 and 6, 150,000 cells per well), and
the immunoblots were scanned by densitometry. (Top, lanes 1, 2,
and 3) Control, untreated cells; (lanes 4, 5, and 6) thapsigargin-
treated cells. (Bottom) The slope of the cell number as a function
of OD was obtained by a linear fit to give a relative cellular con-
tent of calreticulin (Mery et al., 1996). TG, thapsigargin.
Figure 5. Nuclear run-on analysis of the calreticulin gene in NIH/
3T3 cells. Nuclei were isolated from cells treated for 4 h with
DMSO (Control), 10 mM A23187 (A23187), or 100 nM thapsigar-
gin (Thapsigargin), and transcription was allowed to proceed in
the presence of [32P]UTP as described in Materials and Methods.
RNA products from equal numbers of nuclei per sample were hy-
bridized to immobilized single-stranded DNA probes that detect
sense (S) or antisense (AS) transcript arising from calreticulin,
actin, G3PDH, H2b, and c-myc genes. CRT-1, calreticulin 50
probe;  CRT-2, calreticulin 30 probe; actin-1, g-actin 30 probe; ac-
tin-2, g-actin 50 probe.Waser et al. Calreticulin Gene 553
lated and relative levels of calreticulin mRNA were as-
sessed using Northern blot analysis. Fig. 7 shows that
treatment with cycloheximide reduced the A23187- and
thapsigargin-dependent increase in calreticulin mRNA
levels by z75%, suggesting that new protein synthesis was
involved in the response. To rule out that these effects
may be due to the cycloheximide-dependent changes in
the intracellular Ca21 concentrations, we measured cyto-
solic Ca21 concentration in the cycloheximide-treated
cells. The basal cytosolic-free Ca21 concentration was not
changed in the cycloheximide-treated cells and was deter-
mined to be 100 6 8 nM (n 5 4) and 110 6 6 nM (n 5 4) in
control and cycloheximide-treated cells, respectively.
Depletion of Ca21 from the Lumen of the ER Activates 
the Calreticulin Promoter
To test whether extracellular concentrations of Ca21 affect
the drug-mediated activation of the calreticulin promoter,
we incubated NCB1 cells in a Ca21-depleted medium sup-
plemented with EGTA. We found that A23187- and
thapsigargin-dependent activation of the promoter was in-
dependent of changes in the extracellular Ca21 concentra-
tion (Fig. 8). These results further indicate that depletion
of Ca21 from ER stores is involved in the activation of the
calreticulin promoter.
The Effects of BAPTA/AM and EGTA/AM on Activity 
of the Calreticulin Promoter
To test whether activation of the calreticulin promoter by
A23187 and thapsigargin is affected by changes in the cy-
toplasmic Ca21 concentration, NCB1 cells were treated
with the membrane-permeable Ca21 chelators BAPTA/
AM (10 mM) or EGTA/AM (10 mM) before treatment
with the drugs. Once BAPTA/AM or EGTA/AM enter
the cytosol, they are cleaved to membrane-impermeable
BAPTA or EGTA. They significantly reduce and main-
tain a low (resting or below) cytoplasmic Ca21 concentra-
tion (Muallem et al., 1990; Preston and Berlin, 1992). For
example, we showed that the basal cytosolic Ca21 concen-
tration in the BAPTA-treated cells was reduced to 65 6 9
nM (n 5 4) as compared with the control cells (100 6 5
nM (n 5 4)). NCB1 cells were loaded with BAPTA/AM
or EGTA/AM for 30 min followed by 16-h incubation with
either A23187 or thapsigargin, in normal or Ca21-depleted
medium. Fig. 8 shows that in BAPTA-treated cells the
A23187- and thapsigargin-dependent activation of the cal-
reticulin promoter was reduced by 50 and 30%, respec-
tively. Depletion of extracellular Ca21 further enhanced
these effects, especially for cells treated with thapsigargin
(Fig. 8). In contrast, loading of NCB1 cells with EGTA/
AM, a cytoplasmic Ca21 chelator, had no effect on
A23187- or thapsigargin-dependent activation of the cal-
reticulin promoter (Fig. 8).
The Effects of Bradykinin on Activity of the 
Calreticulin Promoter
To investigate if there is any transactivation of the calretic-
ulin promoter under more physiological conditions of
Ca21 store depletion, we treated the NCB1 cells with
Figure 6. The kinetics of activation of the calreticulin promoter
by A23187 and thapsigargin treatment. NCB1 cells (stably ex-
pressing CAT under control of the calreticulin promoter and
b-galactosidase) were incubated with 7 mM A23187, 100 nM
thapsigargin, or DMSO (control cells) for the times indicated. At
different time points, cells were either harvested (open bars) or
washed with PBS and then incubated in drug-free media to a to-
tal of 16 h of incubation (cross-hatched bars). CAT protein levels
and b-galactosidase activity were measured as described in Mate-
rials and Methods. Data are reported as a mean 6 SD of four
separate experiments performed in triplicate.
Figure 7. Cycloheximide in-
hibits the A23187- and thapsi-
gargin-dependent increase of
calreticulin mRNA levels. To-
tal RNA was isolated from
nontransfected NIH/3T3 cells
that had been incubated for
16–18 h with 7 mM A23187 or
100 nM thapsigargin, and ei-
ther with or without cyclo-
heximide. The RNA was sep-
arated electrophoretically on
a formaldehyde-agarose gel,
blotted onto Hybond N ny-
lon filters, and hybridized
with cDNA probes encod-
ing mouse calreticulin and
G3PDH as described in Ma-
terials and Methods. (Top)
Autoradiogram of a Northern
blot probed with calreticulin
and the G3PDH cDNAs.
(Lane  1) Control cells; (lane
2) cells incazxubated with
100  mM cycloheximide; (lane
3) A23187-treated cells; (lane
4) A23187- and cyclohex-
imide-treated  cells; (lane 5)
thapsigargin-treated cells; (lane 6) thapsigargin- and cyclohexi-
mide-treated cells. (Bottom) The abundance of calreticulin mRNA
(calreticulin mRNA/G3PDH mRNA ratio) was determined using
Phosphorimager analysis of the Northern blots. (Filled bars)
Cells treated with A23187 or thapsigargin in the absence of cyclo-
heximide; (open bars) cells pretreated with 100 mM cyclohexi-
mide for 2 h followed by incubation with either A23817 or thapsi-
gargin. TG, thapsigargin.The Journal of Cell Biology, Volume 138, 1997 554
bradykinin in Ca21-free DME supplemented with EGTA.
Bradykinin induces Ca21 depletion of the intracellular
Ca21 stores in the NIH/3T3 cells (Hashii et al., 1993). Fig. 9
shows that prolonged treatment of the NCB1 cells with
bradykinin in the absence of the extracellular Ca21 re-
sulted in a fourfold activation of the calreticulin promoter,
suggesting that bradykinin-dependent Ca21 depletion of
Ca21 stores activates transcription of the calreticulin gene.
In contrast, incubation of the NCB1 cells with bradykinin
for a shorter period of time (4 h), either in the absence or
presence of the extracellular Ca21 followed by incubation
in bradykinin-free media, did not activate the promoter
(data not shown).
Discussion
In this study we have isolated the mouse calreticulin gene
and determined its genomic organization. Using a reporter
gene assay system, we demonstrated that the calreticulin
gene is activated by either thapsigargin-, A23187-, or
bradykinin-dependent Ca21 depletion of intracellular Ca21
stores both in vitro and in vivo. Importantly, run-on exper-
iments documented that depletion of Ca21 stores also acti-
vate endogenous calreticulin gene.2 Finally, we showed
that stress response to ER Ca21 store depletion results in
increased calreticulin mRNA and protein levels, and that
this increased expression of the calreticulin gene requires
de novo protein synthesis.
To initiate this study we first isolated and characterized
a 12-kb genomic DNA fragment containing the entire
mouse calreticulin gene and 2.14 kb of its promoter region.
This allowed us, for the first time, to compare the nucle-
otide sequence of the two genes encoding calreticulin. The
mouse gene is highly homologous to the human gene (Mc-
Cauliffe et al., 1992). With the exception of two introns,
which, in the mouse, are twice the size of their human
counterparts, the exon–intron organizations of these genes
are basically identical. This high degree of conservation at
the level of gene organization and its nucleotide sequence
is in keeping with earlier observations that the amino acid
sequences of calreticulin from different species are also
highly conserved (Nash et al., 1994; Michalak, 1996). For
example, the amino acid sequence identity of mouse and
human calreticulins is .95% (Smith and Koch, 1989; Mc-
Cauliffe et al., 1992).
To investigate the role of the ER Ca21 stores in activa-
tion of calreticulin gene expression, we used two different
agents, the Ca21 ionophore A23187 and the ER Ca21-ATP-
ase inhibitor thapsigargin. We found that these drugs are
associated with activation of the calreticulin promoter in
vitro and in vivo, as well as with increased expression of
calreticulin mRNA and protein. Activation of the calretic-
ulin promoter by these drugs is independent of changes in
extracellular Ca21 concentration. Most importantly, we
show that transactivation of calreticulin promoter is in-
creased in cells treated with bradykinin, a hormone that
induces Ca21 release from Ca21 stores in NIH/3T3 cells
(Fu et al., 1992; Hashii et al., 1993). Bradykinin stimula-
tion of cells leads to activation of protein kinase C. How-
ever, the bradykinin-dependent activation of calreticulin
promoter was not due to the activation of protein kinase C
since phorbol esters had no effect on transactivation of the
calreticulin promoter as measured using the reporter gene
assay system (unpublished observations).
In this study we used a relatively large fragment of the
calreticulin promoter, which allowed us to identify two re-
gions (2115 to 2260 and 2685 to 21,763) in the promoter
Figure 8. Effects of BAPTA on A23187- and thapsigargin-
dependent activation of calreticulin promoter. NCB1 cells were
loaded with 10 mM BAPTA/AM for 30 min in a media containing
different drugs for 16 h and lysed, and reporter gene analysis was
carried out as described in Materials and Methods. (Open bars)
Cells grown and incubated with 7 mM A23187 or 100 nM thapsi-
gargin in DME supplemented with 100 mM EGTA; (dotted bars)
cells loaded with BAPTA/AM followed by incubation with either
A23187 or thapsigargin (control cells were not treated with
BAPTA/AM); (filled bars) cells loaded with BAPTA/AM and in-
cubated with either A23187 or thapsigargin in Ca21-depleted
DME. (Cross-hatched bars) Cells loaded with 10 mM EGTA/AM
for 30 min followed by 16-h incubation with either A23187 or
thapsigargin in DME (control cells were not treated with EGTA/
AM); data are shown as a mean 6 SD.
Figure 9. Effects of bradykinin on activation of calreticulin pro-
moter. NCB1 cells were incubated with either 100 nM thapsigar-
gin (TG) or 200 nM bradykinin (BK) in Ca21-depleted DME sup-
plemented with EGTA. After 16 h the cells were lysed, and then
reporter gene analysis was carried out as described in Materials
and Methods. Data are shown as a mean 6 SD.
2. Since submission of this manuscript, publications by Lewellyn et al.
(1996) and Nguyen et al. (1996) showed Ca21-dependent induction of ex-
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containing unique CCAAT nucleotide motifs that may
play a role in the Ca21 depletion–dependent activation of
the gene. Similar regions have been identified on the
Grp78 promoter and shown to be responsible for the
thapsigargin- and Ca21 ionophore–mediated transactiva-
tion of the gene (Wooden et al., 1991; Li et al., 1993; Roy
and Lee, 1995; Roy et al., 1996). This motif may therefore
play a specific role in Ca21-sensitive regulation of calretic-
ulin genes. It is important to note, however, that CCAAT
element alone may not be sufficient for promoter activa-
tion since another cellular promoter, the a2(I) collagen
promoter, which contains a similar motif, is only weakly
inducible by Ca21 depletion signal (Roy and Lee, 1995;
Roy et al., 1996). It is unlikely, therefore, that there is a
single element responsible for Ca21 depletion–dependent
activation of gene expression. We are currently investigat-
ing, using gel retardation and site-specific mutagenesis
techniques, a precise role of the two regions in the calretic-
ulin promoter in Ca21 store depletion–dependent activa-
tion of the calreticulin gene. Increases in expression of the
calreticulin gene required prolonged exposure to Ca21
ionophore, thapsigargin, or bradykinin (z4 h), and it was
inhibited by cycloheximide, indicating that the calreticulin
gene belongs to a group of “delayed response” genes that
are activated slowly and typically require new protein syn-
thesis for their expression. The mechanism(s) responsible
for the Ca21 depletion–dependent activation of calreticu-
lin and other genes is not yet known. One possibility is that
the treatment of cells with A23187, thapsigargin, or brady-
kinin leads to a brief Ca21 elevation in the cytoplasm,
which may be sufficient to activate long-term effects on
calreticulin gene expression several hours later. However,
this is unlikely since the short-term exposure of cells to
A23187, thapsigargin, or bradykinin either in the presence
or absence of the extracellular Ca21 has no effect on the
transactivation of the calreticulin gene. Whether or not
changes in the nuclear-free Ca21 or nuclear Ca21 binding
proteins (Bachs et al., 1992) are involved remains to be de-
termined. Thus, we conclude that induction of the calretic-
ulin gene is likely due to a stress response upon ER Ca21
store depletion.
Recently, Nguyen et al. (1996) and Llewellyn et al.
(1996) reported activation of the human calreticulin gene
by Ca21 and/or Ca21 store depletion. Llewellyn et al.
(1996) and Nguyen et al. (1996) used a relatively short
fragment of the human calreticulin promoter (585 and 504
bp, respectively) and therefore observed only threefold in-
duction of expression of the calreticulin gene. This is likely
due to transactivation of the first region of the promoter
identified in the present study. An interesting observation
is that calreticulin promoter is also activated by Zn21
(Nguyen et al., 1996). We show that BAPTA, a chelator of
Ca21 and heavy metals (including Zn21), partially inhibits
activation of the calreticulin promoter elicited by A23187
or thapsigargin treatment. In contrast, EGTA/AM, which
has a higher specificity for Ca21 than BAPTA, had no ef-
fect on A23187- and thapsigargin-dependent activation of
the gene. This indicates that cytoplasmic Ca21 may not
play a significant role in the A23187- or thapsigargin-
dependent activation of the calreticulin gene. It is tempt-
ing to speculate, however, that alterations in cytoplasmic
heavy metals (perhaps Zn21 concentration) may play a
role in transactivation of the calreticulin gene. Baksh et al.
(1995) discovered that Zn21 and Ca21 profoundly affect
interactions between calreticulin and PDI, the two ER-
resident proteins. In the presence of Ca21 or Zn21, the two
proteins do not associate (Baksh et al., 1995). Therefore,
change in the Zn21 concentration may not only transacti-
vate calreticulin gene but, if elevated in the lumen of the
ER, it may also modulate levels of “free” calreticulin and/
or PDI in the lumen of the ER (Krause and Michalak,
1997). Understanding the significance of Zn21-dependent
transactivation of calreticulin gene awaits further investi-
gation.
What is the significance of Ca21 store depletion–depen-
dent transactivation of calreticulin gene? Calreticulin is a
multifunctional protein: it modulates steroid-sensitive
gene expression (Burns et al., 1994; Dedhar et al., 1994),
cellular adhesiveness (Coppolino et al., 1996; Opas et al.,
1996), and the store-operated Ca21 influx (Bastianutto et
al., 1995; Mery et al., 1996). Furthermore, the protein is a
unique and unusual chaperone as it interacts specifically
with glucosylated proteins (Hammond and Helenius, 1995;
Helenius et al., 1997). It remains to be determined why
cells upregulate the expression of calreticulin under these
conditions. It is conceivable that overexpression of calretic-
ulin, a Ca21 binding protein (Bastianutto et al., 1995; Mery
et al., 1996), may be required to overcome depletion of the
ER Ca21 stores. Alternatively, changes in the intraluminal
ER Ca21 concentration will affect protein translation,
folding, and posttranslational modification, and increased
expression of calreticulin might be necessary to fulfill re-
quirements for chaperone activity. In this study we show
Ca21 store depletion–dependent regulation of expression
of calreticulin, a new mechanism responsible for the con-
trol of expression of the protein. This will likely have an
important role in the regulation of many cellular processes
that are under the control of calreticulin.
We have recently established that the ER form of cal-
reticulin is responsible for the modulation of steroid-sensi-
tive gene expression (Michalak et al., 1996) and for the
regulation of cellular adhesiveness via upregulation of ex-
pression of vinculin (Opas et al., 1996). Thus, we proposed
that calreticulin may function as a “signaling” molecule
from the lumen of the ER (Mery et al., 1996; Opas et al.,
1996; Michalak et al., 1996; Krause and Michalak, 1997).
This may be similar to the BiP-dependent ER-nuclear sig-
nal transduction described in the yeast (Mori et al., 1993,
1996; Cox et al., 1993; Cox and Walter, 1996; Sidrauski et
al., 1996); control of cellular cholesterol homeostasis by
SREBP, an ER integral membrane protein (Wang et al.,
1994); or ER-dependent activation of the NF-kB (Pahl
and Baeuerle, 1995; Pahl et al., 1996; for review see Pahl
and Baeuerle, 1997). It is conceivable, therefore, that de-
pletion of Ca21 stores not only acts as an ER–nucleus sig-
naling pathway but it may also, via upregulation of expres-
sion of calreticulin as documented in this work, affect the
calreticulin-dependent ER–nucleus/cytoplasm signaling.
This may be a new mechanism of Ca21-dependent modu-
lation of numerous biological and pathophysiological pro-
cesses.
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